Citas
EPINEURO. Ministerio de Salud, Asociación Colombina de Neurología.Bogotá 1999.
Uribe CS, Jiménez I, Mora MO, Mora L, Arana A, SánchezJL, Zuluaga L, et al. Epidemiología de las Enfermedades Cerebrovasculares en Sabaneta, Colombia (1992-1993). Revista de Neurología 1997; 25:1008-1012.
Wolfe CDA. The impacto f stroke. British Medicam Bulletin 2000;56:275-286.
Pérez GE. Enfermedad cerebrovascualr en Cali, Colombia. Editorial.
Acta Neurol Colomb 2004; 20:97-98.
Zuñiga G, Pérez IV, Estrada J, Alvarez J, Larrañaga AL, Pérez C, Castillo E, Moreno DF. Registro de enfermedad cerebrovascualr: incidencia, tipos de ictus y factores de riesgo asociados. Acta Neurol Colomb 2004; 20:116-123.
Saposnik G, Del Brutto OH. Stroke in South America. A systematic review of incidence, prevalence and stroke suptypes. Stroke 2003;3421103-2107.
Boden-Albala B, Sacco RL. Socioeconomic status and stroke mortality: redefining the relationship. Stroke 2002:33:274-275.
Silva FA, Zarruk JG, Silva S, Bernal O, Rueda-Clausen F, Pradilla G, Camacho P, et al. Estudio de correlación entre marcadores de inflamación y grosor íntima media carotídeo, en pacientes con ataque cerebrovascular isquémico. Acta Neurol Colomb 2005;22:3-11.
Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, Juo SH, Sacco RL. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: The northern manhattan prospective cohort study. Stroke 2002;33:1420-1423.
Wright CB, Sacco RLRundek TR, Delman JB, Rabbani LE,. Elkind, MS. Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis 2006; 15: 34-38.
Paoletti R, Gotto AM, Jr, Hajjar DP. Inflammation in Atherosclerosis and Implications for Therapy. Circulation 2004;109[suppl III]: 2 -26.
Wilson AM, Ryan MC, Boyle AJ. The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen. International Journal of Cardiology 2006;106: 291 - 297.
Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C,. Emsley H, et al. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke. A Statement for Health Care Professionals From the CRP Pooling Project Members. Stroke 2005;36:1316-1329.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.